Trials / Completed
CompletedNCT05362318
Project HEALS (Helping and Empowering pAtients for Living a Life Smoke-free
Motivating Smoking Cessation and Relapse Prevention Among Lung Cancer Patients: Helping and Empowering pAtients for Living a Life Smoke-free (Project HEALS)
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 21 (actual)
- Sponsor
- H. Lee Moffitt Cancer Center and Research Institute · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of the study is to pilot test a multi-modal smoking cessation and relapse prevention intervention with the lung cancer patient population and to obtain preliminary data on its feasibility.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Nicotine patch and lozenges | Participants will receive nicotine patch and lozenges. The regimen will be based on the participant's self-reported smoking rate. At the time of enrollment, a research staff member will determine the proper dose. Participants who smoke \>10 cigarettes/day will receive 8 weeks of 21 mg. patches, 2 weeks of 14 mg. patches, 2 weeks of 7 mg. patches, and 12 weeks of 2 mg. lozenges. Those who smoke \<10 cigarettes/day will receive 8 weeks of 14 mg. patches, 4 weeks of 7 mg patches, and 12 weeks of 2 mg. lozenges |
| BEHAVIORAL | Telephone counseling sessions | Participants will be offered 6 Motivation and Problem Solving (MAPS)-based counseling sessions by phone over a 6-month period. |
| BEHAVIORAL | Access to a web-based video | Participants will be given web-based access to the relapse prevention video "Surviving Smokefree". |
| BEHAVIORAL | Florida Tobacco Quitline | Participants will receive an offer of enrollment to the Florida Tobacco Quitline which enables participant to speak with a Quit Coach who will assess nicotine addiction and help create a quit plan. |
Timeline
- Start date
- 2021-06-07
- Primary completion
- 2023-01-28
- Completion
- 2023-01-28
- First posted
- 2022-05-05
- Last updated
- 2026-04-06
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT05362318. Inclusion in this directory is not an endorsement.